0001209191-11-048122.txt : 20110916
0001209191-11-048122.hdr.sgml : 20110916
20110916131054
ACCESSION NUMBER: 0001209191-11-048122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110915
FILED AS OF DATE: 20110916
DATE AS OF CHANGE: 20110916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 111094532
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-09-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2011-09-15
4
M
0
9500
11.27
A
143235
D
Common Stock
2011-09-15
4
S
0
5492
50.03
D
137743
D
Common Stock
2011-09-15
4
S
0
4008
50.42
D
133735
D
Common Stock
4495
I
401(k)
Stock Options
11.27
2011-09-15
4
M
0
9500
0.00
D
2014-10-06
Common stock
5200
3300
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $50.03 (range $49.81 to $50.19).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $50.42 (range $50.20 to $50.96).
Fully vested.
Kenneth S. Boger, Attorney-In-Fact
2011-09-16